These genes have been previously implicated in other cancer types, and RNA m6-A methyltransferases in general have been a topic of recent interest in the new field of cancer epitranscriptomics, with several phase I trials targeting METTL3 due to begin in 2021 [21]. Here, METTL3 is linked to cancer.